Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM(R) and NABI-HB(R)

americanpharmaceuticalreviewAugust 11, 2021

Tag: ADMA , Bivigam , NABI-HB

PharmaSources Customer Service